Gynecologic Cancers

Latest News

HPV Vaccinations Lowered HPV-Caused Cancers Rates in Patients Under the Age of 40
HPV Vaccinations Lowered HPV-Caused Cancers Rates in Patients Under the Age of 40

May 25th 2024

HPV vaccines in patients under the age of 40 may have lowered rates of HPV-related cancer compared with unvaccinated patients.

HPV Self-Collection Test for Cervical Cancer Receives FDA Approval
HPV Self-Collection Test for Cervical Cancer Receives FDA Approval

May 15th 2024

Image of a checklist that says FDA.
Tisotumab Vedotin-tftv Approved by FDA in Advanced Cervical Cancer

April 29th 2024

Nurse Intervention Approach Feasible in Addressing Cancer Symptom Clusters
Nurse Intervention Approach Feasible in Addressing Cancer Symptom Clusters

April 28th 2024

Inconsistent Symptom Clusters Warrant Routine Assessments in Older Patients With Cancer
Inconsistent Symptom Clusters Warrant Routine Assessments in Older Patients With Cancer

April 25th 2024

Latest CME Events & Activities

Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies

View More

Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer

View More

8th Annual School of Nursing Oncology™

August 10, 2024

Register Now!

Applying New Evidence in Multiple Myeloma Care from Frontline to R/R Disease

View More

Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?

View More

Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!

View More

Medical Crossfire: How Has Iron Supplementation Altered Treatment Planning for Patients with Cancer-Related Anemia?

View More

The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…

View More

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

View More

More News

© 2024 MJH Life Sciences

All rights reserved.